Proteomic analysis of proteins released from growth-arrested Candida albicans following exposure to caspofungin

References

• Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis 1998; 31: 327–332.
   PubMed Web of Science ®Google Scholar
• Sudbery P, Gow N, Berman J. The distinct morphogenic states of Candida albicans. Trends Microbiol 2004; 12: 317–324
   PubMed Web of Science ®Google Scholar
• Odds FC. Candida and Candidosis A Review and Bibliography, 2nd edn.London, UK: Bailliere Tindall, 1988.
   Google Scholar
• Matthews R, Burnie J. The epidemiology and pathogenesis of candidiasis: applications in prevention and treatment. Bull Inst Pasteur 1998; 96: 249–256
   Google Scholar
• Kartsonis NA, Nielsen J, Douglas CM. Caspofungin: the first in a new class of antifungal agents. Drug Resist Update 2003; 6: 197–218
   PubMed Web of Science ®Google Scholar
• Eggimann P, Garbino J, Pittet D. Management of Candida species infections in critically ill patients. Lancet Infect Dis 2003; 3: 772–785
   PubMed Web of Science ®Google Scholar
• Kurtz MB, Douglas CM. Lipopeptide inhibitors of fungal glucan synthase. J Med Vet Mycol 1997; 35: 79–86
   PubMedGoogle Scholar
• Onishi J, Meinz M, Thompson J, . Discovery of novel antifungal (1,3)-β-D-glucan synthase inhibitors. Antimicrob Agents Chemother 2000; 44: 368–377
   PubMed Web of Science ®Google Scholar
• Walker LA, Munro CA, de Bruijn I, . Stimulation of chitin synthesis rescues Candida albicans from echinocandins. PLoS Pathog 2008; 4: e1000040.
   PubMed Web of Science ®Google Scholar
• Stevens DA, Ichinomiya M, Koshi Y, Horiuchi H. Escape of Candida from caspofungin inhibition at concentrations above the MIC (Paradoxical Effect) accomplished by increased cell wall chitin: evidence for β-1,6-glucan synthesis inhibition by caspofungin. Antimicrob Agents Chemother 2006; 50: 3160–3161
   PubMed Web of Science ®Google Scholar
• Munro CA, Selvaggini S, deBruijn I, . The PKC, HOG and Ca2+ signalling pathways co-ordinately regulate chitin synthesis in Candida albicans. Mol Microbiol 2007; 63: 1399–1413
   PubMed Web of Science ®Google Scholar
• Reinoso-Martin C, Schuller C, Schuetzer-Muehlbauer M, Kuchler K. The yeast protein kinase C cell integrity pathway mediates tolerance to the antifungal drug caspofungin through activation of Slt2p mitogen-activated protein kinase signaling. Eukaryot Cell 2003; 2: 1200–1210
   PubMed Web of Science ®Google Scholar
• Wheeler RT, Fink GR. A drug-sensitive genetic network masks fungi from the immune system. PLoS Pathog 2006; 2 (4, e35): 328–339.
   Google Scholar
• Wheeler RT, Kombe D, Agarwala SD, Fink GR. Dynamic, morphotype-specific Candida albicans β-glucan exposure during infection and drug treatment. PLoS Pathog 2008; 4(12): e1000227.
   Google Scholar
• Ghosh A, Ghosh JJ. Release of intracellular constituents of Candida albicans in presence of polyene antibiotics. Ann Biochem Exp Med 1963; 23: 611–626
   Google Scholar
• Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 2006; 1: 2856–2860
   PubMed Web of Science ®Google Scholar
• Yu ZW, Quinn PJ. Solvation effects of dimethyl sulphoxide on the structure of phospholipid bilayers. Biophys Chem 1998; 70: 35–39
   PubMed Web of Science ®Google Scholar
• Reeves EP, Murphy T, Daly P, Kavanagh K. Amphotericin B enhances the synthesis and release of the immunosuppressive agent gliotoxin from the pulmonary pathogen Aspergillus fumigatus. J Med Microbiol 2004; 53: 719–725
   PubMed Web of Science ®Google Scholar
• Angiolella L, Facchin M, Stringaro A, . Identification of a glucan-associated enolase as a main cell wall protein of Candida albicans and an indirect target of lipopeptide antimycotics. J Infect Dis 1996; 173: 684–690
   PubMed Web of Science ®Google Scholar
• Pitarch A, Sanchez M, Nombela C, Gil C. Sequential fractionation and two-dimensional gel analysis unravels the complexity of the dimorphic fungus Candida albicans cell wall proteome. Mol Cell Proteomics 2002; 1: 967–982
   PubMed Web of Science ®Google Scholar
• Ishiguro A, Homma M, Torii S, Tanaka K. Identification of Candida albicans antigens reactive with immunoglobulin E antibody of human sera. Infect Immun 1992; 60: 1550–1557
   PubMed Web of Science ®Google Scholar
• Ito K, Ishiguro A, Kanbe T, Tanaka K, Torii S. Detection of IgE antibody against Candida albicans enolase and its cross-reactivity to Saccharomyces cerevisiae enolase. Clin Exp Allergy 1995; 25: 522–528
   Google Scholar
• Strockbine NA, Largen MT, Zweibel SM, Buckley HR. Identification and molecular weight characterization of antigens from Candida albicans that are recognized by human sera. Infect Immun 1984; 43: 715–721
   PubMed Web of Science ®Google Scholar
• Pitarch A, Pardo M, Jimenez A, . Two-dimensional gel electrophoresis as analytical tool for identifying Candida albicans immunogenic proteins. Electrophoresis 1999; 20: 1001–1010
   Google Scholar
• Shen HD, Choo KB, Lee HH, . The 40-kilodalton allergen of Candida albicans is an alcohol dehydrogenase: molecular cloning and immunological analysis using monoclonal antibodies. Clin Exp Allergy 1991; 21: 675–681.
   Google Scholar
• Swoboda RK, Bertram G, Hollander H, . Glycolytic enzymes of Candida albicans are non-ubiquitous immunogens during candidiasis. Infect Immun 1993; 61: 4263–4271
   PubMed Web of Science ®Google Scholar
• Crowe JD, Sievwright IK, Auld GC, . Candida albicans binds human plasminogen: identification of eight plasminogen-binding proteins. Mol Microbiol 2003; 47: 1637–1651
   Web of Science ®Google Scholar
• Klotz SA, Pendrak ML, Hein RC. Antibodies to α5β1 and αvβ3 integrins react with Candida albicans alcohol dehydrogenase. Microbiology 2001; 147: 3159–3164
   PubMed Web of Science ®Google Scholar
• Alloush HM, Lopez-Ribot JL, Mastern BJ, Chaffin WL. 3-phosphoglycerate kinase: a glycolytic enzyme protein present in the cell wall of Candida albicans. Microbiology 1997; 143: 321–330
   PubMed Web of Science ®Google Scholar
• Pitarch A, Abian J, Carrascal M, . Proteomics-based identification of novel Candida albicans antigens for diagnosis of systemic candidiasis in patients with underlying hematological malignancies. Proteomics 2004; 4: 3084–3106
   PubMed Web of Science ®Google Scholar
• Gil-Navarro I, Gil ML, Casanova M, Martinez JP, Gozalbo D. The glycolytic enzyme glyceraldehyde-3-phosphate-dehydrogenase of Candida albicans is a surface antigen. J Bacteriol 1997; 179: 4992–4999
   PubMed Web of Science ®Google Scholar
• Gozalbo D, Gil-Navarro I, Azorin I, . The cell wall-associated glyceraldehyde-3-phosphate dehydrogenase of Candida albicans is also a fibronectin and laminin binding protein. Infect Immun 1998; 66: 2052–2059
   PubMed Web of Science ®Google Scholar
• Pardo M, Ward M, Pitarch A, . Cross-species identification of novel Candida albicans immunogenic proteins by combination of two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. Electrophoresis 2000; 21: 2651–2659
   Google Scholar
• Stubbs HJ, Brasch DJ, Emerson GW, Sullivan PA. Hydrolase and transferase activities of the β-1,3-exoglucanase of Candida albicans. Eur J Biochem 1999; 263: 889–895
   PubMedGoogle Scholar
• Castillo L, Calvo E, Martinez AI, . A study of the Candida albicans cell wall proteome. Proteomics 2008; 8: 3871–3881
   PubMed Web of Science ®Google Scholar
• Lamaris GA, Lewis RE, Chamilos G, . Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae. J Infect Dis 2008; 198: 186–192
   PubMed Web of Science ®Google Scholar